{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:13:59Z","timestamp":1793124839575,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.32060208, No.82260532"],"award-info":[{"award-number":["No.32060208, No.82260532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81771524, No.81471416"],"award-info":[{"award-number":["No.81771524, No.81471416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General program of Guangxi Natural Science Foundation","award":["No.2019JJA140071"],"award-info":[{"award-number":["No.2019JJA140071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02486-4","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:49:50Z","timestamp":1764766190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetically platform presenting CD24 ScFv enhance antitumor immunity by restoring macrophage phagocytosis and modulating the immune environment"],"prefix":"10.1186","volume":"23","author":[{"given":"Guannan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"7","key":"2486_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43(7):546\u201363.","journal-title":"Trends Immunol"},{"issue":"1","key":"2486_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2486_CR3","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.3802\/jgo.2024.35.e87","volume":"35","author":"Y Kobayashi","year":"2024","unstructured":"Kobayashi Y, Shimada M, Tamate M, Cho HW, Zhu J, Chou HH, et al. Current treatment strategies for ovarian cancer in the East Asian gynecologic oncology trial group (EAGOT). J Gynecol Oncol. 2024;35(3):e87.","journal-title":"J Gynecol Oncol"},{"issue":"7553","key":"2486_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015;521(7553):489\u201394.","journal-title":"Nature"},{"issue":"1","key":"2486_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41422-023-00909-w","volume":"34","author":"LP Ge","year":"2024","unstructured":"Ge LP, Jin X, Ma D, Wang ZY, Liu CL, Zhou CZ, et al. ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer. Cell Res. 2024;34(1):58\u201375.","journal-title":"Cell Res"},{"issue":"5","key":"2486_CR6","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.medj.2024.100571","volume":"6","author":"LP Ge","year":"2025","unstructured":"Ge LP, Jiang YZ. Combination of autophagy inhibitors with high-dose CDK4\/6 inhibitors offers new hope for advanced HR+\/HER2- breast cancer. Med. 2025;6(5):100571.","journal-title":"Med"},{"issue":"2","key":"2486_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00262-023-03606-0","volume":"73","author":"X Li","year":"2024","unstructured":"Li X, Tian W, Jiang Z, Song Y, Leng X, Yu J. Targeting CD24\/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions. Cancer Immunol Immunother. 2024;73(2):31.","journal-title":"Cancer Immunol Immunother"},{"issue":"5922","key":"2486_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1126\/science.1168988","volume":"323","author":"GY Chen","year":"2009","unstructured":"Chen GY, Tang J, Zheng P, Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 2009;323(5922):1722\u20135.","journal-title":"Science"},{"issue":"17","key":"2486_CR9","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1182\/bloodadvances.2023011934","volume":"8","author":"JAC van Bruggen","year":"2024","unstructured":"van Bruggen JAC, Peters FS, Mes M, Rietveld JM, Cerretani E, Cretenet G, et al. T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells. Blood Adv. 2024;8(17):4633\u201346.","journal-title":"Blood Adv"},{"key":"2486_CR10","doi-asserted-by":"crossref","unstructured":"Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. CD24: A novel target for cancer immunotherapy. J Pers Med. 2022;12(8):1235.","DOI":"10.3390\/jpm12081235"},{"key":"2486_CR11","doi-asserted-by":"publisher","first-page":"1183285","DOI":"10.3389\/fimmu.2023.1183285","volume":"14","author":"Y Gu","year":"2023","unstructured":"Gu Y, Zhou G, Tang X, Shen F, Ding J, Hua K. The biological roles of CD24 in ovarian cancer: old story, but new Tales. Front Immunol. 2023;14:1183285.","journal-title":"Front Immunol"},{"issue":"1","key":"2486_CR12","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1038\/s41598-024-61516-2","volume":"14","author":"VM Perelmuter","year":"2024","unstructured":"Perelmuter VM, Grigoryeva ES, Savelieva OE, Alifanov VV, Andruhova ES, Zavyalova MV, et al. EpCAM-CD24\u2009+\u2009circulating cells associated with poor prognosis in breast cancer patients. Sci Rep. 2024;14(1):12245.","journal-title":"Sci Rep"},{"issue":"7769","key":"2486_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572(7769):392\u20136.","journal-title":"Nature"},{"issue":"2","key":"2486_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.31557\/APJCP.2024.25.2.513","volume":"25","author":"Y Feharsal","year":"2024","unstructured":"Feharsal Y, Andrijono A, Singoprawiro CS, Lisnawati L, Pakasi TA, Putra AD, et al. Role of CD44 and CD24 expression on 2-years disease free survival in patients with advanced epithelial ovarian carcinoma. Asian Pac J Cancer Prev. 2024;25(2):513\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"2486_CR15","doi-asserted-by":"publisher","first-page":"114041","DOI":"10.1016\/j.celrep.2024.114041","volume":"43","author":"AK Mishra","year":"2024","unstructured":"Mishra AK, Ye T, Banday S, Thakare RP, Su CT, Pham NNH, et al. Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer. Cell Rep. 2024;43(4):114041.","journal-title":"Cell Rep"},{"issue":"11","key":"2486_CR16","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1021\/acsnano.3c00804","volume":"17","author":"Q Li","year":"2023","unstructured":"Li Q, Song Q, Zhao Z, Lin Y, Cheng Y, Karin N, et al. Genetically engineered artificial Exosome-Constructed hydrogel for ovarian cancer therapy. ACS Nano. 2023;17(11):10376\u201392.","journal-title":"ACS Nano"},{"key":"2486_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/OTT.S366625","volume":"15","author":"SL Christian","year":"2022","unstructured":"Christian SL. CD24 as a potential therapeutic target in patients with B-Cell leukemia and lymphoma: current insights. Onco Targets Ther. 2022;15:1391\u2013402.","journal-title":"Onco Targets Ther"},{"key":"2486_CR18","doi-asserted-by":"publisher","first-page":"122662","DOI":"10.1016\/j.biomaterials.2024.122662","volume":"311","author":"X Dong","year":"2024","unstructured":"Dong X, Liu H, Fang C, Zhang Y, Yang Q, Wang H, et al. Sonocatalytic Oncolysis microbiota curb intrinsic microbiota lactate metabolism and Blockade CD24-Siglec10 immune escape to revitalize immunological surveillance. Biomaterials. 2024;311:122662.","journal-title":"Biomaterials"},{"key":"2486_CR19","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.omto.2023.100747","volume":"31","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wu H, Yang Y, Kang Y, He R, Zhou B, et al. Dual Blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy. Mol Ther Oncolytics. 2023;31:100747.","journal-title":"Mol Ther Oncolytics"},{"issue":"2","key":"2486_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/odi.14367","volume":"30","author":"KL Zou","year":"2024","unstructured":"Zou KL, Lan Z, Cui H, Zhao YY, Wang WM, Yu GT. CD24 Blockade promotes anti-tumor immunity in oral squamous cell carcinoma. Oral Dis. 2024;30(2):163\u201371.","journal-title":"Oral Dis"},{"issue":"7","key":"2486_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/bjc.2013.102","volume":"108","author":"AV Salnikov","year":"2013","unstructured":"Salnikov AV, Bretz NP, Perne C, Hazin J, Keller S, Fogel M, et al. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas. Br J Cancer. 2013;108(7):1449\u201359.","journal-title":"Br J Cancer"},{"key":"2486_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ygyno.2024.07.002","volume":"189","author":"B McNamara","year":"2024","unstructured":"McNamara B, Greenman M, Bellone S, Santin LA, Demirkiran C, Mutlu L, et al. Preclinical activity of Datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma. Gynecol Oncol. 2024;189:16\u201323.","journal-title":"Gynecol Oncol"},{"key":"2486_CR23","doi-asserted-by":"publisher","first-page":"789939","DOI":"10.3389\/fendo.2021.789939","volume":"12","author":"G Zhou","year":"2021","unstructured":"Zhou G, Gu Y, Zhou F, Zhang H, Zhang M, Zhang G, et al. Adipocytes-Derived extracellular Vesicle-miR-26b promotes apoptosis of cumulus cells and induces polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:789939.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2486_CR24","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s12013-024-01340-7","volume":"82","author":"D Sun","year":"2024","unstructured":"Sun D, Altalbawy FMA, Yumashev A, Hjazi A, Menon SV, Kaur M, et al. Shedding light on the role of Exosomal PD-L1 (ExoPD-L1) in cancer progression: an update. Cell Biochem Biophys. 2024;82(3):1709\u201320.","journal-title":"Cell Biochem Biophys"},{"issue":"7","key":"2486_CR25","doi-asserted-by":"publisher","first-page":"e12490","DOI":"10.1002\/jev2.12490","volume":"13","author":"R Chen","year":"2024","unstructured":"Chen R, Kang Z, Li W, Xu T, Wang Y, Jiang Q, et al. Extracellular vesicle surface display of \u03b1PD-L1 and \u03b1CD3 antibodies via engineered late domain-based scaffold to activate T-cell anti-tumor immunity. J Extracell Vesicles. 2024;13(7):e12490.","journal-title":"J Extracell Vesicles"},{"key":"2486_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1755-8794-2-71","volume":"2","author":"NJ Bowen","year":"2009","unstructured":"Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics. 2009;2:71.","journal-title":"BMC Med Genomics"},{"issue":"W1","key":"2486_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"2486_CR28","doi-asserted-by":"crossref","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: A web tool for the comparison of gene expression in Normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22(5):2622.","DOI":"10.3390\/ijms22052622"},{"issue":"26","key":"2486_CR29","doi-asserted-by":"publisher","first-page":"e2312219","DOI":"10.1002\/adma.202312219","volume":"36","author":"X Li","year":"2024","unstructured":"Li X, Guo Q, Chen Q, Chu Y, Zhang Y, Chen H, et al. Reconciling the Cooperative-Competitive patterns among tumor and immune cells for Triple-Negative breast cancer treatment using multimodule nanocomplexes. Adv Mater. 2024;36(26):e2312219.","journal-title":"Adv Mater"},{"issue":"3","key":"2486_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/ijms20030660","volume":"20","author":"RA-O Klapdor","year":"2019","unstructured":"Klapdor RA-O, Wang S, Morgan M, D\u00f6rk T, Hacker U, Hillemanns PA-O, et al. Characterization of a novel Third-Generation Anti-CD24-CAR against ovarian cancer. Int J Mol Sci. 2019;20(3):660.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2486_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12964-025-02226-8","volume":"23","author":"G Zhou","year":"2025","unstructured":"Zhou G, Gu Y, Zhang M, Ding J, Lu G, Hua K, et al. Identification of genetically engineered strategies to manipulate nano-platforms presenting immunotherapeutic ligands for alleviating primary ovarian insufficiency progression. Cell Commun Signal. 2025;23(1):246.","journal-title":"Cell Commun Signal"},{"key":"2486_CR32","doi-asserted-by":"publisher","first-page":"162635","DOI":"10.1016\/j.cej.2025.162635","volume":"512","author":"Y Gu","year":"2025","unstructured":"Gu Y, Zhou G, Zhang M, Lu G, Shen F, Qi B, et al. Bioengineered extracellular vesicles presenting PD-L1 and Gal-9 to ameliorate new-onset primary ovarian insufficiency (POI). Chem Eng J. 2025;512:162635.","journal-title":"Chem Eng J"},{"issue":"1","key":"2486_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13048-025-01672-9","volume":"18","author":"M Zhang","year":"2025","unstructured":"Zhang M, Gu Y, Shen F, Gong Y, Gu Z, Hua K, et al. Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy. J Ovarian Res. 2025;18(1):95.","journal-title":"J Ovarian Res"},{"key":"2486_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-0716-3203-1_5","volume":"2668","author":"R Yuan","year":"2023","unstructured":"Yuan R, Zhou Y, Arias GF, Dittmer DP. Extracellular vesicle isolation by a Tangential-Flow Filtration-Based Large-Scale purification method. Methods Mol Biol. 2023;2668:45\u201355.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2486_CR35","doi-asserted-by":"publisher","first-page":"e12207","DOI":"10.1002\/jev2.12207","volume":"11","author":"M Wolf","year":"2022","unstructured":"Wolf M, Poupardin RW, Ebner-Peking P, Andrade AC, Bl\u00f6chl C, Obermayer A, et al. A functional Corona around extracellular vesicles enhances angiogenesis, skin regeneration and Immunomodulation. J Extracell Vesicles. 2022;11(4):e12207.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2486_CR36","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"2486_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10(+)GPR77(+) cancer-Associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841\u2013e5616.","journal-title":"Cell"},{"issue":"5","key":"2486_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25(5):605\u201320.","journal-title":"Cancer Cell"},{"issue":"7964","key":"2486_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","volume":"618","author":"G Wang","year":"2023","unstructured":"Wang G, Li J, Bojmar L, Chen H, Li Z, Tobias GC, et al. Tumour extracellular vesicles and particles induce liver metabolic dysfunction. Nature. 2023;618(7964):374\u201382.","journal-title":"Nature"},{"issue":"4","key":"2486_CR40","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1021\/acsnano.9b10033","volume":"14","author":"BS Joshi","year":"2020","unstructured":"Joshi BS, de Beer MA, Giepmans BNG, Zuhorn IS. Endocytosis of extracellular vesicles and release of their cargo from endosomes. ACS Nano. 2020;14(4):4444\u201355.","journal-title":"ACS Nano"},{"issue":"1","key":"2486_CR41","doi-asserted-by":"publisher","first-page":"1697028","DOI":"10.1080\/20013078.2019.1697028","volume":"9","author":"Y Tian","year":"2020","unstructured":"Tian Y, Gong M, Hu Y, Liu H, Zhang W, Zhang M, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2020;9(1):1697028.","journal-title":"J Extracell Vesicles"},{"key":"2486_CR42","doi-asserted-by":"crossref","unstructured":"Zhang J, Brown A, Johnson B, Diebold D, Asano K, Marriott G et al. Genetically engineered extracellular vesicles harboring transmembrane scaffolds exhibit differences in their Size, expression levels of specific surface markers and Cell-Uptake. Pharmaceutics. 2022;14(12):2564.","DOI":"10.3390\/pharmaceutics14122564"},{"issue":"4","key":"2486_CR43","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","volume":"18","author":"W Pei","year":"2024","unstructured":"Pei W, Zhang Y, Zhu X, Zhao C, Li X, L\u00fc H, et al. Multitargeted Immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles. ACS Nano. 2024;18(4):2782\u201399.","journal-title":"ACS Nano"},{"issue":"9","key":"2486_CR44","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4049\/jimmunol.2400035","volume":"213","author":"B Ma","year":"2024","unstructured":"Ma B, Kamle S, Sadanaga T, Lee CM, Lee JH, Yee DC, et al. Chitinase 3-like-1 inhibits innate antitumor and tissue remodeling immune responses by regulating CD47-SIRP\u03b1- and CD24-Siglec10-Mediated phagocytosis. J Immunol. 2024;213(9):1279\u201391.","journal-title":"J Immunol"},{"key":"2486_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jconrel.2022.11.017","volume":"352","author":"S Liu","year":"2022","unstructured":"Liu S, Lv K, Wang Y, Lou P, Zhou P, Wang C, et al. Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy. J Control Release. 2022;352:1009\u201323.","journal-title":"J Control Release"},{"issue":"5","key":"2486_CR46","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.ymthe.2021.10.009","volume":"30","author":"R Zhang","year":"2022","unstructured":"Zhang R, Fu Y, Cheng M, Ma W, Zheng N, Wang Y, et al. sEVs(RVG) selectively delivers antiviral SiRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model. Mol Ther. 2022;30(5):2078\u201391.","journal-title":"Mol Ther"},{"issue":"1","key":"2486_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-024-03955-2","volume":"15","author":"F Tang","year":"2024","unstructured":"Tang F, Dong T, Zhou C, Deng L, Liu HB, Wang W, et al. Genetically engineered human induced pluripotent stem cells for the production of brain-targeting extracellular vesicles. Stem Cell Res Ther. 2024;15(1):345.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"2486_CR48","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1021\/acsnano.3c10547","volume":"18","author":"Y Long","year":"2024","unstructured":"Long Y, Yang B, Lei Q, Gao F, Chen L, Chen W, et al. Targeting senescent alveolar epithelial cells using engineered mesenchymal stem Cell-Derived extracellular vesicles to treat pulmonary fibrosis. ACS Nano. 2024;18(9):7046\u201363.","journal-title":"ACS Nano"},{"issue":"33","key":"2486_CR49","doi-asserted-by":"publisher","first-page":"eaaz0748","DOI":"10.1126\/sciadv.aaz0748","volume":"6","author":"TT Tang","year":"2020","unstructured":"Tang TT, Wang B, Wu M, Li ZL, Feng Y, Cao JY, et al. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv. 2020;6(33):eaaz0748.","journal-title":"Sci Adv"},{"key":"2486_CR50","doi-asserted-by":"crossref","unstructured":"Yang Z, Zhang Z, Li L, Jing Z, Ma Y, Lan T et al. Bioengineered artificial extracellular vesicles presenting PD-L1 and Gal-9 ameliorate New-onset type 1 diabetes. Diabetes. 2024.","DOI":"10.2337\/figshare.25837810.v1"},{"issue":"13","key":"2486_CR51","doi-asserted-by":"publisher","first-page":"e12163","DOI":"10.1002\/jev2.12163","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C, Sun M, Wang J, Su L, Lin J, Yan X. Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour. J Extracell Vesicles. 2021;10(13):e12163.","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"2486_CR52","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1007\/s12274-023-5374-3","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Hu S, Zhu D, Li J, Cheng K, Liu G. Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentials. Nano Res. 2023;16(5):7248\u201359.","journal-title":"Nano Res"},{"issue":"8","key":"2486_CR53","doi-asserted-by":"publisher","first-page":"e12352","DOI":"10.1002\/jev2.12352","volume":"12","author":"Y Fan","year":"2023","unstructured":"Fan Y, Pionneau C, Cocozza F, Bo\u00eblle PY, Chardonnet S, Charrin S, et al. Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. J Extracell Vesicles. 2023;12(8):e12352.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2486_CR54","doi-asserted-by":"publisher","first-page":"1663043","DOI":"10.1080\/20013078.2019.1663043","volume":"8","author":"G Corso","year":"2019","unstructured":"Corso G, Heusermann W, Trojer D, G\u00f6rgens A, Steib E, Voshol J, et al. Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule - single vesicle level by fluorescence correlation spectroscopy and single particle imaging. J Extracell Vesicles. 2019;8(1):1663043.","journal-title":"J Extracell Vesicles"},{"issue":"10","key":"2486_CR55","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/jev2.12130","volume":"10","author":"AM Silva","year":"2021","unstructured":"Silva AM, L\u00e1zaro-Ib\u00e1\u00f1ez E, Gunnarsson A, Dhande A, Daaboul G, Peacock B, et al. Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution. J Extracell Vesicles. 2021;10(10):e12130.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2486_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12951-024-02567-5","volume":"22","author":"J Chen","year":"2024","unstructured":"Chen J, Zhang E, Wan Y, Huang T, Wang Y, Jiang H. A quick and innovative pipeline for producing chondrocyte-homing peptide-modified extracellular vesicles by three-dimensional dynamic culture of hADSCs spheroids to modulate the fate of remaining ear chondrocytes in the M1 macrophage-infiltrated microenvironment. J Nanobiotechnol. 2024;22(1):300.","journal-title":"J Nanobiotechnol"},{"key":"2486_CR57","doi-asserted-by":"publisher","first-page":"31027","DOI":"10.3402\/jev.v5.31027","volume":"5","author":"ME Hung","year":"2016","unstructured":"Hung ME, Leonard JN. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J Extracell Vesicles. 2016;5:31027.","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"2486_CR58","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cac2.12539","volume":"44","author":"GR Khosravi","year":"2024","unstructured":"Khosravi GR, Mostafavi S, Bastan S, Ebrahimi N, Gharibvand RS, Eskandari N. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun (Lond). 2024;44(5):521\u201353.","journal-title":"Cancer Commun (Lond)"},{"key":"2486_CR59","doi-asserted-by":"publisher","first-page":"111781","DOI":"10.1016\/j.intimp.2024.111781","volume":"130","author":"C Shao","year":"2024","unstructured":"Shao C, Yan X, Pang S, Nian D, Ren L, Li H, et al. Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model. Int Immunopharmacol. 2024;130:111781.","journal-title":"Int Immunopharmacol"},{"issue":"22","key":"2486_CR60","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2013-12-545335","volume":"123","author":"T Toubai","year":"2014","unstructured":"Toubai T, Hou G, Mathewson N, Liu C, Wang Y, Oravecz-Wilson K, et al. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. Blood. 2014;123(22):3512\u201323.","journal-title":"Blood"},{"issue":"8","key":"2486_CR61","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cmet.2022.07.005","volume":"34","author":"X Wang","year":"2022","unstructured":"Wang X, Liu M, Zhang J, Brown NK, Zhang P, Zhang Y, et al. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. Cell Metab. 2022;34(8):1088\u2013e1036.","journal-title":"Cell Metab"},{"issue":"1","key":"2486_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41392-022-01030-x","volume":"7","author":"M Liu","year":"2022","unstructured":"Liu M, Wang X, Du X, Zhang Y, Ai C, Hu-Lieskovan S, et al. CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect. Signal Transduct Target Ther. 2022;7(1):224.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"2486_CR63","doi-asserted-by":"publisher","first-page":"e2108817","DOI":"10.1002\/adma.202108817","volume":"34","author":"M Hou","year":"2022","unstructured":"Hou M, Wei Y, Zhao Z, Han W, Zhou R, Zhou Y, et al. Immuno-Engineered nanodecoys for the Multi-Target Anti-Inflammatory treatment of autoimmune diseases. Adv Mater. 2022;34(12):e2108817.","journal-title":"Adv Mater"},{"key":"2486_CR64","doi-asserted-by":"publisher","first-page":"114305","DOI":"10.1016\/j.ejca.2024.114305","volume":"211","author":"M Mandal\u00e0","year":"2024","unstructured":"Mandal\u00e0 M, Ferrari A, Brecht IB, Suijkerbuijk KP, Maschke L, Giannarelli D, et al. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study). Eur J Cancer. 2024;211:114305.","journal-title":"Eur J Cancer"},{"issue":"9","key":"2486_CR65","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41591-024-03088-2","volume":"30","author":"H Mo","year":"2024","unstructured":"Mo H, Yu Y, Sun X, Ge H, Yu L, Guan X, et al. Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a bayesian adaptive randomized phase 2 trial. Nat Med. 2024;30(9):2528\u201339.","journal-title":"Nat Med"},{"issue":"26","key":"2486_CR66","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455\u201365.","journal-title":"N Engl J Med"},{"issue":"8","key":"2486_CR67","first-page":"2269","volume":"18","author":"S Taghiloo","year":"2017","unstructured":"Taghiloo S, Allahmoradi E, Ebadi R, Tehrani M, Hosseini-Khah Z, Janbabaei G, et al. Upregulation of Galectin-9 and PD-L1 immune checkpoints molecules in patients with chronic lymphocytic leukemia. Asian Pac J Cancer Prev. 2017;18(8):2269\u201374.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"2486_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/blood.2023020250","volume":"143","author":"J Magenau","year":"2024","unstructured":"Magenau J, Jaglowski S, Uberti J, Farag SS, Riwes MM, Pawarode A, et al. A phase 2 trial of CD24Fc for prevention of graft-versus-host disease. Blood. 2024;143(1):21\u201331.","journal-title":"Blood"},{"issue":"1","key":"2486_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-021-01222-y","volume":"15","author":"NJ Song","year":"2022","unstructured":"Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, et al. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. J Hematol Oncol. 2022;15(1):5.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2486_CR70","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010;9(4):325\u201338.","journal-title":"Nat Rev Drug Discov"},{"issue":"9205","key":"2486_CR71","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(00)01034-5","volume":"355","author":"FC Breedveld","year":"2000","unstructured":"Breedveld FC. Therapeutic monoclonal antibodies. Lancet. 2000;355(9205):735\u201340.","journal-title":"Lancet"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02486-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T14:03:22Z","timestamp":1764770602000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02486-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02486-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Obstetrics and Gynecology Hospital of Fudan University Institutional Review Board, the approve number is 2019-77. Informed consent was obtained from all human participants involved in the study. All animal procedures were performed in accordance with the protocol approved by the Institutional Animal Care and Use Committee at the Fudan University (SYXK2020-0032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"517"}}